BSX logo Boston Scientific Corporation +
Boston Scientific Corporation
+

Boston Scientific Corporation Overview

Company: Boston Scientific Corporation
CEO: Michael F. Mahoney
Founded: 1979
Symbol: BSX
Exchange: NYSE
Industry: Medical - Devices
Sector: Healthcare
About

Boston Scientific Corporation (BSX) operates as a global leader in medical technology, specializing in the design, manufacturing, and commercialization of innovative medical devices tailored for a diverse array of interventional medical specialties across the globe. Its business is strategically organized into three principal segments: MedSurg, Rhythm and Neuro, and Cardiovascular. Within these divisions, the company provides a comprehensive portfolio of solutions addressing various gastrointestinal and pulmonary ailments, as well as urological and pelvic health concerns. This extends to advanced implantable devices for managing cardiac rhythm disorders, such as cardioverter-defibrillators, cardiac resynchronization therapy devices, and pacemakers, complemented by remote patient management systems. Furthermore, Boston Scientific offers sophisticated technologies for diagnosing and treating complex heart rate and rhythm irregularities. These encompass 3-D cardiac mapping and navigation tools, along with a suite of specialized catheters (including ablation, diagnostic, mapping, and intracardiac ultrasound types), delivery sheaths, and related accessories. Its offerings also extend to neurological conditions, providing spinal cord stimulator systems for chronic pain management, indirect decompression systems, and deep brain stimulation systems. In the realm of interventional cardiology, the company's innovationslude drug-eluting coronary stent systems designed for treating coronary artery disease, products for percutaneous coronary interventions to combat atherosclerosis, and intravascular imaging catheters (such as ultrasound and fractional flow reserve devices) for assessing coronary arteries, heart chambers, and peripheral vessels. It also develops structural heart therapies. Beyond this, Boston Scientific supplies an array of stents, balloon catheters, wires, and atherectomy systems for the treatment of arterial diseases. For venous conditions, it provides thrombectomy and acoustic pulse thrombolysis systems, alongside wires and stents. Critically, the company also contributes to cancer treatment through peripheral embolization devices, radioactive microspheres, various ablation systems (including cryotherapy), and micro and drainage catheters. The organization was established in 1979 and maintains its corporate headquarters in Marlborough, Massachusetts.

Continue reading...

Boston Scientific Corporation (BSX)

  • Stock Price
  • Volume
44.65 +1.91 +4.47%
Past 5 Years
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • 10Y
  • ALL

Revenue

Boston Scientific Corporation annual revenue was $20.07 B in 2025.

Net Income

Boston Scientific Corporation annual net income was $2.89 B in 2025.

Employees

Boston Scientific Corporation annual employee count was 59,000 in 2025.

Revenue by Segment

Boston Scientific Corporation’s revenue by segment: Cardiovascular: $13.27 B and MedSurg: $6.83 B in 2025.

Revenue by Region

Boston Scientific Corporation’s revenue by region: Non-US: $7.21 B and UNITED STATES: $12.86 B in 2025.

Executive Salary

Michael F. Mahoney Chairman of the Board, President and Chief Execut...

Revenue per Employee

Boston Scientific Corporation revenue per employee was $340.24 K in 2025.

Profit per Employee

Boston Scientific Corporation profit per employee was $48.92 K in 2025.

Income Statement

Operating Income

Boston Scientific Corporation annual operating income was $3.97 B in 2025.

Research & Development

Boston Scientific Corporation annual research & development expense was $2.05 B in 2025.

Tax Rate (%)

Boston Scientific Corporation annual Tax Rate was 15.00% in 2025.

Assets & Liabilities | Cash Flow

Total Assets

Boston Scientific Corporation annual total assets was $43.67 B in 2025.

Total Liabilities

Boston Scientific Corporation annual total liabilities was $19.20 B in 2025.

Capital Expenditure

Boston Scientific Corporation annual capital expenditures was -$876.00 M in 2025.

Ratios

Return on Equity (ROE)

Boston Scientific Corporation annual return on equity(ROE) was 0.00% in 2025.

Return on Assets (ROA)

Boston Scientific Corporation annual return on assets(ROA) was 0.00% in 2025.

Debt to Equity

Boston Scientific Corporation annual debt to equity was 51.24% in 2025.

Profitability

Gross Profit Margin (%)

Boston Scientific Corporation annual gross profit margin was 69.01% in 2025.

Operating Income Margin (%)

Boston Scientific Corporation annual operating income margin was 19.78% in 2025.

Net Income Margin (%)

Boston Scientific Corporation annual net income margin was 14.38% in 2025.

Earning Per Share

Boston Scientific Corporation annual earning per share was $1.95 in 2025.

EBITDA

Boston Scientific Corporation annual EBITDA was $3.73 B in 2025.

Free Cash Flow (FCF)

Boston Scientific Corporation annual free cash flow(FCF) was $3.66 B in 2025.

Valuation

Enterprise value

Boston Scientific Corporation annual enterprise value was - in 2025.

Enterprise value to Revenue

Boston Scientific Corporation annual enterprise value to revenue was 0.00 in 2025.

Enterprise value to EBITDA

Boston Scientific Corporation annual enterprise value to EBITDA was 0.00 in 2025.

Competitors’ Revenue

Frequently Asked Questions

When was Boston Scientific Corporation founded?

Boston Scientific Corporation was founded on 1979, which makes the company 47 years old.

Sign up for free to view

Who is the CEO of Boston Scientific Corporation?

Michael F. Mahoney is the CEO of Boston Scientific Corporation.

What industry and sector is Boston Scientific Corporation in?

Boston Scientific Corporation operates in the Medical - Devices industry and the Healthcare sector.

What are Boston Scientific Corporation's CIK, SIC, and ISIN codes?

  • CIK (Central Index Key): 0000885725
  • SIC (Standard Industrial Classification): 3841
  • ISIN (International Securities Identification Number): US1011371077

Sign up for free to view

How many employees does Boston Scientific Corporation have?

Boston Scientific Corporation has 59,000 employees.

What is the revenue of Boston Scientific Corporation?

In fiscal year 2025, Boston Scientific Corporation generated a revenue of $20.07 Billion.

What is the net income of Boston Scientific Corporation?

In fiscal year 2025, Boston Scientific Corporation reported a net income of $2.89 Billion.

What is Boston Scientific Corporation's biggest product segment?

Cardiovascular is Boston Scientific Corporation's biggest product segment, representing 66.02% of its total revenue.

When was Boston Scientific Corporation listed on the stock exchange?

Boston Scientific Corporation went public on May 19, 1992, through its Initial Public Offering (IPO), and it has been 34 years since then.

Sign up for free to view

What is the ticker symbol of Boston Scientific Corporation, and where is it listed?

Boston Scientific Corporation's ticker symbol is BSX, and the company is listed on the NYSE stock market exchange.

What is Boston Scientific Corporation's current stock price?

Boston Scientific Corporation's current stock price is $44.66 as of Jul 14, 2026.

What is Boston Scientific Corporation's market capitalization?

As of , Boston Scientific Corporation's market cap is .

What is Boston Scientific Corporation's ranking in the world?

Ranked #31among 2,804 companies based on market cap.

Who are the top competitors of Boston Scientific Corporation?

Competitors of Boston Scientific Corporation include Stryker Corporation, Abbott Laboratories and DexCom, and more.

People Also Search For

Submit feedback to Bullfincher